Novo Nordisk is testing semaglutide in a late-stage trial in patients ... Chronic kidney disease Novo's Ozempic is approved ...

TORONTO – Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes.  Between 30 and 50 per cent of people with Type 2 diabetes ...

Investing.com -- Danish drugmaker Novo Nordisk (NYSE: NVO) announced Tuesday that Canada’s health regulator has approved its diabetes drug Ozempic for additional uses related to kidney disease.

Novo Nordisk announced Monday that people who use Ozempic can now get it for half the price if you pay in cash.

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and ...

Andersen has a fair value estimate of $71 for Novo stock. Closing around $52.41 on Aug. 15 (near its lowest level since ...

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially ...

T elemedicine company GoodRx ( GDRX) has been helping Americans find the cheapest way to buy drugs for years. Thanks to a new ...

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...